Comments on the discordant recommendations for the use of symptomatic slow-acting drugs in knee osteoarthritis
Journal article
Reginster, Jean Yves, Cooper, Cyrus, Hochberg, Marc, Pelletier, Jean Pierre, Rizzoli, R, Kanis, John A., Abadie, Eric, Maheu, E., Brandi, Maria Luisa, Devogelaer, J. P., Branco, J., Herrero-Beaumont, G., D'Hooghe, Pieter and Bruyère, O.. (2015). Comments on the discordant recommendations for the use of symptomatic slow-acting drugs in knee osteoarthritis. Current Medical Research and Opinion. 31(5), pp. 1041 - 1045. https://doi.org/10.1185/03007995.2015.1027183
Authors | Reginster, Jean Yves, Cooper, Cyrus, Hochberg, Marc, Pelletier, Jean Pierre, Rizzoli, R, Kanis, John A., Abadie, Eric, Maheu, E., Brandi, Maria Luisa, Devogelaer, J. P., Branco, J., Herrero-Beaumont, G., D'Hooghe, Pieter and Bruyère, O. |
---|---|
Abstract | Despite the near concurrent publication by influential scientific organizations, there are important differences in interpretation of the evidence base and the conclusions derived from the recent Osteoarthritis Research Society International (OARSI) guidelines for the management of knee osteoarthritis, the American College of Rheumatology (ACR) guidelines (concerning also hip and hand osteoarthritis) and the algorithm recommendations by the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO). This is particularly evident for the drug class of symptomatic slow-acting drugs in osteoarthritis. In this paper, we highlight these differences and try to understand where they derive from, proposing an evidence-based interpretation. |
Keywords | chondroitin; glucosamine; hyaluronic acid; osteoarthritis; symptomatic slow-acting drugs in osteoarthritis |
Year | 2015 |
Journal | Current Medical Research and Opinion |
Journal citation | 31 (5), pp. 1041 - 1045 |
Publisher | Informa Healthcare |
ISSN | 0300-7995 |
Digital Object Identifier (DOI) | https://doi.org/10.1185/03007995.2015.1027183 |
Scopus EID | 2-s2.0-84928177249 |
Page range | 1041 - 1045 |
Research Group | Institute for Health and Ageing |
Publisher's version | File Access Level Controlled |
Place of publication | United Kingdom |
https://acuresearchbank.acu.edu.au/item/8qq69/comments-on-the-discordant-recommendations-for-the-use-of-symptomatic-slow-acting-drugs-in-knee-osteoarthritis
Restricted files
Publisher's version
161
total views0
total downloads2
views this month0
downloads this month